Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4IDE8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.575 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.364 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.575 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.392 |
CLV_PCSK_PC7_1 | 74 | 80 | PF00082 | 0.443 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.623 |
DEG_MDM2_SWIB_1 | 48 | 56 | PF02201 | 0.404 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.386 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.347 |
LIG_14-3-3_CanoR_1 | 12 | 21 | PF00244 | 0.394 |
LIG_14-3-3_CanoR_1 | 23 | 32 | PF00244 | 0.452 |
LIG_Actin_WH2_2 | 42 | 59 | PF00022 | 0.394 |
LIG_BIR_III_4 | 88 | 92 | PF00653 | 0.562 |
LIG_deltaCOP1_diTrp_1 | 88 | 97 | PF00928 | 0.616 |
LIG_LIR_Gen_1 | 25 | 34 | PF02991 | 0.375 |
LIG_LIR_Gen_1 | 71 | 80 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.579 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.574 |
LIG_Pex14_2 | 48 | 52 | PF04695 | 0.289 |
LIG_REV1ctd_RIR_1 | 95 | 101 | PF16727 | 0.669 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.547 |
LIG_TYR_ITIM | 36 | 41 | PF00017 | 0.345 |
LIG_TYR_ITIM | 45 | 50 | PF00017 | 0.277 |
LIG_UBA3_1 | 53 | 61 | PF00899 | 0.428 |
LIG_WRC_WIRS_1 | 94 | 99 | PF05994 | 0.616 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.448 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.431 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.546 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.427 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.661 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.648 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.422 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.445 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.386 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.418 |
MOD_PKB_1 | 77 | 85 | PF00069 | 0.555 |
MOD_Plk_1 | 27 | 33 | PF00069 | 0.479 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.581 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.197 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.251 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.547 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.379 |
TRG_ER_diArg_1 | 76 | 79 | PF00400 | 0.600 |
TRG_Pf-PMV_PEXEL_1 | 99 | 103 | PF00026 | 0.476 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P701 | Leptomonas seymouri | 77% | 100% |
A0A1X0P839 | Trypanosomatidae | 55% | 100% |
A0A3Q8IK31 | Leishmania donovani | 100% | 100% |
A0A422NLR1 | Trypanosoma rangeli | 57% | 100% |
A4HP41 | Leishmania braziliensis | 89% | 100% |
D0A325 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
E9ASU9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q1P7 | Leishmania major | 97% | 100% |
V5B4H5 | Trypanosoma cruzi | 56% | 100% |